Patents by Inventor Balaguru Murugesan

Balaguru Murugesan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • An Automated Projectile Loader And A Method Of Loading Projectiles For A Vehicle
    Publication number: 20240077265
    Abstract: An automated projectile loader and a method of loading projectile for a vehicle is disclosed. The automated projectile loader includes a carousal projectile unit mounted on a hull of the vehicle. The carousal projectile unit includes a carousal storage adapted to store a plurality of projectiles oriented in a vertical direction. The automated projectile loader includes a bustle projectile unit disposed at a rear end of a turret of the vehicle. The bustle projectile unit includes a bustle storage adapted to store a plurality of projectiles and propellants oriented in a horizontal direction. The automated projectile loader includes an automated arm disposed below the turret and adapted to load the plurality of projectiles from one of the carousal storage and the bustle storage in a barrel orientated in any angle in the turret.
    Type: Application
    Filed: January 7, 2022
    Publication date: March 7, 2024
    Inventors: Babu NATESAN, Roshan SAMUEL RAJA RAJESH KUMAR, Balaguru VADIVEL, Rajakumar RAI S, Dhanpal MURUGESAN
  • Process for the preparation of crystalline form I of methanesulfonate salt of dabigatran etexilate
    Patent number: 9150542
    Abstract: The present invention relates to a process for the preparation of crystalline Form I of methanesulfonate salt of dabigatran etexilate. (Formula (I)). The present invention does not require the isolation of the dabigatran etexilate intermediate.
    Type: Grant
    Filed: September 2, 2013
    Date of Patent: October 6, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Anandam Vempali, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20150246899
    Abstract: The present invention relates to a process for the preparation of dabigatran etexilate. The present invention also relates to trifluoroacetate salt of dabigatran etexilate and a process for its preparation. The present invention further relates to crystalline Form I and crystalline Form II of trifluoroacetate salt of dabigatran etexilate and processes for their preparation. The present invention further relates to a process for the preparation of pharmaceutically acceptable salts, including methanesulfonate salt, of dabigatran etexilate.
    Type: Application
    Filed: September 30, 2013
    Publication date: September 3, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Anandam Vempali, Sudhir Singh Sanwal, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20150225370
    Abstract: The present invention provides hydrobromide salt of dabigatran etexilate of formula (IV) and its process for the preparation. The present invention further provides crystalline Form I and crystalline Form II of hydrobromide salt of dabigatran etexilate and processes for their preparation. The present invention further relates to a process for the preparation of pharmaceutically ac ceptable salts, including methanesulfonate salt, of dabigatran etexilate using hydrobromide salt of dabigatran etexilate of the present invention.
    Type: Application
    Filed: September 30, 2013
    Publication date: August 13, 2015
    Inventors: Anandam Vempali, Sudhir Singh Sanwal, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF METHANESULFONATE SALT OF DABIGATRAN ETEXILATE
    Publication number: 20150197504
    Abstract: The present invention relates to a process for the preparation of crystalline Form I of methanesulfonate salt of dabigatran etexilate. (Formula (I)). The present invention does not require the isolation of the dabigatran etexilate intermediate.
    Type: Application
    Filed: September 2, 2013
    Publication date: July 16, 2015
    Inventors: Sudhir Singh Sanwal, Anandam Vempali, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
    Patent number: 8440823
    Abstract: The present invention relates to a process for preparation of erlotinib of Formula I or its pharmaceutically acceptable salt thereof. The present invention also relates to process for the preparation of erlotinib trifluoroacetate. The present invention also relates to a nove-ICrystalline form of erlotinib trifluoroacetate designated as Form E and process for its preparation. The present invention further relates to process for the preparation of erlotinib hydrochloride from erlotinib trifluoroacetate.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: May 14, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESSES FOR THE PREPARATION OF ERLOTINIB HYDROCHLORIDE FORM A AND ERLOTINIB HYDROCHLORIDE FORM B
    Publication number: 20120302749
    Abstract: The present invention relates to processes for the preparation of erlotinib hydrochloride Form A and erlotinib hydrochloride Form B. (I).
    Type: Application
    Filed: November 12, 2010
    Publication date: November 29, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF LENALIDOMIDE
    Publication number: 20120184746
    Abstract: The present invention relates to a process for the preparation of lenalidomide, wherein the process comprises: reducing 3-(4-nitro-loxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione to obtain lenalidomide.
    Type: Application
    Filed: September 3, 2010
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Munish Kapoor, Saridi Madhava Dileep Kumar, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF DESLORATADINE
    Publication number: 20120101281
    Abstract: The present invention provides a process for the preparation of desloratadine comprising contacting loratadine with a mixture of a weak inorganic base and sodium or potassium hydroxide in a ratio, ranging from 0.01 to 0.15 equivalents of sodium or potassium hydroxide per equivalent of weak inorganic base, in one or more suitable solvents) followed by isolation.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Swargam Sathyanarayana, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF ERLOTINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20120101272
    Abstract: The present invention relates to a process for preparation of erlotinib of Formula I or its pharmaceutically acceptable salt thereof. The present invention also relates to process for the preparation of erlotinib trifluoroacetate. The present invention also relates to a nove-ICrystalline form of erlotinib trifluoroacetate designated as Form E and process for its preparation. The present invention further relates to process for the preparation of erlotinib hydrochloride from erlotinib trifluoroacetate.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad